NPI: 1437622933 · CHESTER, SC 29706 · General Acute Care Hospital · NPI assigned 01/07/2019
Authorized official RAE, KARYN controls 20+ related entities in our dataset. Read more
| Authorized Official | RAE, KARYN (DIRECTOR) |
| NPI Enumeration Date | 01/07/2019 |
Other providers sharing the same authorized official: RAE, KARYN
| Year | Claims | Total Paid |
|---|---|---|
| 2019 | 41,028 | $1.06M |
| 2020 | 28,593 | $580K |
| 2021 | 33,432 | $606K |
| 2022 | 43,288 | $1.02M |
| 2023 | 34,934 | $1.11M |
| 2024 | 30,519 | $585K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 80053 | Comprehensive metabolic panel | 13,772 | 11,353 | $1.08M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4,729 | 4,348 | $615K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 3,294 | 3,122 | $396K |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 14,189 | 11,851 | $356K |
| 80048 | Basic metabolic panel (calcium, ionized) | 3,235 | 2,768 | $267K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 6,419 | 4,895 | $216K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 2,222 | 1,655 | $210K |
| 81001 | 9,891 | 8,487 | $194K | |
| 36415 | Collection of venous blood by venipuncture | 13,184 | 10,291 | $155K |
| 81025 | 3,948 | 3,687 | $129K | |
| 99284 | Emergency department visit for the evaluation and management, high severity | 11,074 | 9,771 | $108K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 3,302 | 2,701 | $88K |
| J2550 | Injection, promethazine hcl, up to 50 mg | 1,260 | 640 | $69K |
| 71046 | Radiologic examination, chest; 2 views | 2,928 | 2,712 | $64K |
| 87081 | 721 | 692 | $59K | |
| 70450 | Computed tomography, head or brain; without contrast material | 1,840 | 1,613 | $54K |
| 87400 | 1,091 | 1,015 | $49K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1,731 | 1,534 | $43K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 797 | 755 | $42K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1,513 | 1,485 | $41K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2,001 | 1,808 | $41K |
| 82947 | 1,311 | 889 | $40K | |
| J7030 | Infusion, normal saline solution , 1000 cc | 506 | 263 | $34K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 401 | 361 | $31K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 13,940 | 11,333 | $30K |
| 73610 | 343 | 326 | $28K | |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5,847 | 5,042 | $27K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 966 | 258 | $27K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 260 | 222 | $25K |
| 86803 | 347 | 334 | $21K | |
| 87070 | 428 | 362 | $21K | |
| 71045 | Radiologic examination, chest; single view | 4,200 | 3,477 | $18K |
| 87077 | 665 | 541 | $17K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 5,797 | 4,834 | $16K |
| 81003 | 896 | 852 | $16K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 374 | 362 | $16K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1,165 | 1,048 | $16K |
| 87807 | 248 | 243 | $15K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4,303 | 3,612 | $15K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1,363 | 1,167 | $14K |
| 84703 | 317 | 262 | $14K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 122 | 82 | $14K |
| 73630 | 258 | 233 | $14K | |
| 96376 | 796 | 495 | $13K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 80 | 46 | $13K |
| 73560 | 212 | 196 | $11K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 248 | 242 | $11K |
| 85027 | 3,234 | 2,832 | $10K | |
| 96361 | Intravenous infusion, hydration; each additional hour | 1,227 | 1,002 | $10K |
| 96375 | Therapeutic injection; each additional sequential IV push | 3,244 | 2,564 | $9K |
| J7120 | Ringers lactate infusion, up to 1000 cc | 179 | 125 | $9K |
| 80061 | Lipid panel | 777 | 749 | $9K |
| 87430 | 535 | 486 | $9K | |
| 84484 | 6,219 | 3,916 | $8K | |
| 93971 | 40 | 38 | $8K | |
| 85379 | 1,204 | 1,097 | $8K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1,400 | 1,045 | $7K |
| 86710 | 88 | 86 | $7K | |
| 84702 | 100 | 92 | $5K | |
| 85610 | 2,418 | 2,051 | $5K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 97 | 71 | $5K |
| 73030 | 89 | 88 | $5K | |
| 0002A | 89 | 88 | $5K | |
| 99460 | 50 | 50 | $4K | |
| 0001A | 84 | 81 | $4K | |
| 87040 | 1,882 | 1,061 | $4K | |
| 85007 | 1,417 | 1,239 | $3K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 1,002 | 968 | $3K |
| 86900 | 26 | 24 | $3K | |
| 99238 | Hospital discharge day management, 30 minutes or less | 38 | 38 | $3K |
| 72100 | 108 | 104 | $2K | |
| 82962 | 65 | 55 | $2K | |
| 83605 | 2,281 | 1,891 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 3,597 | 3,046 | $2K |
| 87800 | 29 | 26 | $2K | |
| 73130 | 26 | 25 | $2K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 162 | 154 | $1K |
| 87420 | 45 | 42 | $1K | |
| 97161 | 149 | 116 | $1K | |
| 84443 | Thyroid stimulating hormone (TSH) | 1,098 | 1,018 | $1K |
| 82550 | 1,457 | 1,095 | $1K | |
| 73562 | 16 | 16 | $1K | |
| 87186 | 337 | 283 | $1K | |
| G0378 | Hospital observation service, per hour | 859 | 330 | $1K |
| 83735 | 4,194 | 3,540 | $1K | |
| 83880 | 1,681 | 1,462 | $966.40 | |
| 74018 | 14 | 14 | $898.54 | |
| 83690 | 3,186 | 2,709 | $816.80 | |
| 73110 | 14 | 12 | $656.71 | |
| 74019 | 39 | 37 | $620.89 | |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 26 | 13 | $531.76 |
| 73502 | 15 | 15 | $528.32 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 44 | 36 | $524.66 |
| 71250 | 14 | 14 | $481.96 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 89 | 88 | $442.38 |
| 36600 | 247 | 180 | $351.53 | |
| 87150 | 15 | 15 | $310.38 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 269 | 243 | $268.64 |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 985 | 942 | $252.13 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 358 | 343 | $197.05 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 379 | 368 | $188.32 |
| 76882 | 16 | 15 | $177.81 | |
| 84436 | 12 | 12 | $152.64 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 483 | 418 | $85.18 |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 128 | 121 | $75.01 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 3,469 | 2,254 | $18.28 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 2,382 | 2,016 | $15.22 |
| 82247 | 31 | 29 | $12.94 | |
| 86140 | 27 | 26 | $8.54 | |
| 85651 | 110 | 107 | $4.66 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 93 | 90 | $2.80 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 459 | 357 | $0.23 |
| 82803 | 178 | 131 | $0.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 2,107 | 1,791 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 1,661 | 1,309 | $0.00 |
| 85730 | 1,733 | 1,433 | $0.00 | |
| 82553 | 463 | 188 | $0.00 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 559 | 502 | $0.00 |
| 82077 | 56 | 52 | $0.00 | |
| J3490 | Unclassified drugs | 180 | 85 | $0.00 |
| 84075 | 29 | 28 | $0.00 | |
| 80320 | 202 | 185 | $0.00 | |
| 82150 | 98 | 55 | $0.00 | |
| 87205 | 60 | 42 | $0.00 | |
| 82040 | 30 | 28 | $0.00 | |
| 86901 | 12 | 12 | $0.00 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 36 | 26 | $0.00 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 13 | 13 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 38 | 38 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 494 | 359 | $0.00 |
| 82805 | 141 | 111 | $0.00 | |
| J0595 | Injection, butorphanol tartrate, 1 mg | 355 | 144 | $0.00 |
| T1015 | Clinic visit/encounter, all-inclusive | 115 | 98 | $0.00 |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 26 | 26 | $0.00 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 52 | 43 | $0.00 |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 18 | 14 | $0.00 |
| 72125 | Computed tomography, cervical spine; without contrast material | 28 | 27 | $0.00 |
| 84450 | 30 | 28 | $0.00 | |
| 84155 | 31 | 29 | $0.00 | |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 42 | 36 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 26 | 13 | $0.00 |